These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23409523)

  • 1. Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome.
    Godinjak A; Godinjak Z; Burekovic A; Surkovic I; Dizdarevic-Bostandzic A; Velija-Asimi Z
    Med Arch; 2012; 66(6):409-11. PubMed ID: 23409523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of prediabetes in women with polycystic ovary syndrome.
    Ibricevic D; Asimi ZV
    Med Arch; 2013; 67(4):282-5. PubMed ID: 24520755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
    Wehr E; Gruber HJ; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E986-90. PubMed ID: 21470992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Different Obesity Metabolic Indexes and their Correlation with Insulin Resistance in Patients with Polycystic Ovary Syndrome.
    Feng Y; Li M; Li X; Tang Q; Li X; Ji X; Tian W; Zhang H
    Reprod Sci; 2024 Sep; 31(9):2829-2835. PubMed ID: 38649666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.
    Hosseinpanah F; Barzin M; Erfani H; Serahati S; Ramezani Tehrani F; Azizi F
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):52-7. PubMed ID: 23844634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome.
    Uysal E; Tammo O; Soylemez E; Incebıyık M; Filiz D; Alci M
    BMC Endocr Disord; 2024 Aug; 24(1):160. PubMed ID: 39198818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum human Klotho levels and thiol/disulfide homeostasis in women with polycystic ovary syndrome and in healthy women.
    Biyik I; Erten O; Isiklar OO; Ince O; Soysal C; Berikten D; Mammadli S; Oztas E
    Taiwan J Obstet Gynecol; 2021 May; 60(3):487-491. PubMed ID: 33966733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
    Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profile in women with polycystic ovary syndrome across adult life.
    Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
    Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey.
    Mu L; Zhao Y; Li R; Lai Y; Qiao J
    Reprod Biomed Online; 2018 Oct; 37(4):498-504. PubMed ID: 30228071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of different obese criteria for the assessment of insulin resistance in women with polycystic ovary syndrome].
    Chen L; Lan Z; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):945-9. PubMed ID: 24490508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.
    Wiltgen D; Benedetto IG; Mastella LS; Spritzer PM
    Hum Reprod; 2009 Jul; 24(7):1726-31. PubMed ID: 19329517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.